Greedy Insider
Immunovant, Inc. (IMVT) Insider Trades and Scores
Immunovant, Inc. (IMVT) insider trades: since Dec 1, 2025, Greedy Insider recorded 1 open-market buys and 62 sales on Form 4 from 10 insiders. The strongest recent filing scored 95 (Strong).
Who bought and who sold
Across the last 63 scoreable Form 4 transactions in IMVT, 1 were open-market purchases and 62 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.
| Insider | Role | Type | Shares | Date | Score | ||
|---|---|---|---|---|---|---|---|
| Stout Jay S | Chief Technology Officer | Sell | 2595.0 | 75099.3 | 2026-10-21 | 67 | View |
| Van Tuyl Christopher | Chief Legal Officer | Sell | 1327.0 | 42543.62 | 2026-10-07 | 71 | View |
| Gloria Melanie | COO | Sell | 2241.0 | 71846.46 | 2026-10-07 | 76 | View |
| Stout Jay S | Chief Technology Officer | Sell | 2213.0 | 70948.78 | 2026-10-07 | 74 | View |
| Stout Jay S | Chief Technology Officer | Sell | 1596.0 | 51167.76 | 2026-10-07 | 71 | View |
| Venker Eric | CEO | Sell | 3506.0 | 119589.66 | 2026-10-02 | 69 | View |
| Venker Eric | CEO | Sell | 85886.0 | 2890064.0 | 2026-10-01 | 80 | View |
| Van Tuyl Christopher | Chief Legal Officer | Sell | 2846.0 | 103480.56 | 2026-09-23 | 70 | View |
| Pande Atul | Director | Sell | 1500.0 | 64905.0 | 2026-08-28 | 66 | View |
| Gloria Melanie | COO | Sell | 3056.0 | 134952.95 | 2026-08-20 | 74 | View |
The strongest recent filing
Gloria Melanie (COO) sold 14,748 shares of Immunovant, Inc. on Jun 26, 2026, a filing that scored 95 (Strong). It scored Strong because a senior insider was trading and several insiders moved the same way within a week. The score describes the filing, not future returns. This is not investment advice.
Cluster activity
A cluster buy is present: 6 insiders (Venker Eric, Pande Atul, Gloria Melanie, Stout Jay S) traded IMVT the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.
How this compares with Immunovant, Inc.'s own history
Open-market buys make up 2% of the 63 scoreable IMVT transactions on record between Dec 1, 2025 and Oct 21, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.
Methodology and sources
Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.
Key facts
- Scoreable Form 4 transactions on record: 63
- Open-market buys: 1
- Sales: 62
- Distinct insiders: 10
- Strongest recent Greediness Score: 95 (Strong)
Primary sources
Related
- Strongest filing
- IMVT in the live feed
- How the Greediness Score works
- What is a cluster buy?
- Form 4 transaction codes
The score describes the filing, not future returns. This is not investment advice.